MedQuist Holdings Inc. (Nasdaq:MEDH) (the "Company"), a leading provider of integrated clinical documentation solutions for the U.S. healthcare industry, today announced details for the release of its third quarter ended September 30, 2011.

MedQuist Holdings plans to issue its earnings release for the third quarter after the market closes on Wednesday, November 9, 2011, and will host a conference call on Thursday, November 10, 2011, at 8:30 a.m. ET to discuss its third quarter results. The number to call for this interactive teleconference is (212) 231-2901. A replay of the conference call will be available through Thursday, November 17, 2011, by dialing (402) 977-9140 and entering the confirmation number, 21543416.

The live broadcast of MedQuist Holdings' quarterly conference call will be available online at the Company's website, www.medquistholdings.com, under Investor Relations, Events & Webcasts, on Thursday, November 10, 2011, beginning at 8:30 a.m. ET. The online replay will follow shortly after the call and continue for approximately one year. 

About MedQuist Holdings

MedQuist is a leading provider of clinical narrative capture services, Speech Understanding technology from M*Modal and clinical documentation workflow. MedQuist's enterprise solutions – including mobile voice capture devices, speech recognition, Web-based workflow platforms and global network of medical editors – help healthcare facilities facilitate adoption of electronic health records (EHR), improve patient care, increase physician satisfaction and lower operational costs. For more information, please visit www.medquist.com.

The MedQuist Holdings Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10082

CONTACT: Tripp Sullivan
         Corporate Communications, Inc.
         615-324-7335
Medx (CE) (USOTC:MEDH)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Medx (CE).
Medx (CE) (USOTC:MEDH)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Medx (CE).